A26

(2Z)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide

Created: 1999-10-01
Last modified:  2021-03-01

Find related ligands:

Chemical Details

Formal Charge0
Atom Count28
Chiral Atom Count0
Bond Count28
Aromatic Bond Count6
2D diagram of A26

Chemical Component Summary

Name(2Z)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide
SynonymsANTIPROLIFERATIVE AGENT A771726
Systematic Name (OpenEye OEToolkits)(Z)-2-cyano-3-oxidanyl-N-[4-(trifluoromethyl)phenyl]but-2-enamide
FormulaC12 H9 F3 N2 O2
Molecular Weight270.207
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESACDLabs12.01O=C(Nc1ccc(cc1)C(F)(F)F)C(/C#N)=C(\O)C
SMILESCACTVS3.370CC(O)=C(C#N)C(=O)Nc1ccc(cc1)C(F)(F)F
SMILESOpenEye OEToolkits1.7.6CC(=C(C#N)C(=O)Nc1ccc(cc1)C(F)(F)F)O
Canonical SMILESCACTVS3.370 CC(/O)=C(C#N)/C(=O)Nc1ccc(cc1)C(F)(F)F
Canonical SMILESOpenEye OEToolkits1.7.6 C/C(=C(\C#N)/C(=O)Nc1ccc(cc1)C(F)(F)F)/O
InChIInChI1.03 InChI=1S/C12H9F3N2O2/c1-7(18)10(6-16)11(19)17-9-4-2-8(3-5-9)12(13,14)15/h2-5,18H,1H3,(H,17,19)/b10-7-
InChIKeyInChI1.03 UTNUDOFZCWSZMS-YFHOEESVSA-N

Drug Info: DrugBank

DrugBank IDDB08880 
NameTeriflunomide
Groups approved
DescriptionTeriflunomide is the active metabolite of leflunomide, and it acts as an immunomodulatory agent by inhibiting pyrimidine synthesis. It is marketed under the name Aubagio® and is indicated for the treatment of multiple sclerosis, specifically relapsing forms. The FDA label states an important warning about the risk of hepatoxicity and teratogenicity for patients using teriflunomide.
Synonyms
  • Teriflunomide
  • Tériflunomide
  • Teriflunomida
  • (Z)-2-cyano-alpha,alpha,alpha-trifluoro-3-hydroxy-p-crotonotoluidide
  • Teriflunomidum
Brand Names
  • Sandoz Teriflunomide
  • Teriflunomide
  • Jamp Teriflunomide
  • M-teriflunomide
  • Teriflunomide Mylan
IndicationUsed in the treatment of relapsing forms of multiple sclerosis (MS).
Categories
  • Acids, Acyclic
  • Amines
  • Analgesics
  • Analgesics, Non-Narcotic
  • Aniline Compounds
ATC-CodeL04AA31
CAS number163451-81-8

Drug Targets

NameTarget SequencePharmacological ActionActions
Dihydroorotate dehydrogenase (quinone), mitochondrialMAWRHLKKRAQDAVIILGGGGLLFASYLMATGDERFYAEHLMPTLQGLLD...unknowninhibitor
Cytochrome P450 2C8MEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDI...unknowninhibitor
Cytochrome P450 1A2MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL...unknowninducer
ATP-binding cassette sub-family G member 2MSSSNVEVFIPVSQGNTNGFPATASNDLKAFTEGAVLSFHNICYRVKLKS...unknownsubstrate,inhibitor
Solute carrier organic anion transporter family member 1B1MDQNQHLNKTAEAQPSENKKTRYCNGLKMFLAALSLSFIAKTLGAIIMKS...unknowninhibitor
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL973
PubChem 54684141
ChEMBL CHEMBL973
ChEBI CHEBI:68540
CCDC/CSD DOSCUM, DOSCUM02